Tag

CME Archives - JDDonline - Journal of Drugs in Dermatology

Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes

By Aesthetics, CME Activities, Featured Articles No Comments

CME Activities

Earn 1.0 CME Credit: Human facial aging is a gradual and ongoing process involving various factors including photodamage, skin laxity, volume loss of subcutaneous tissue, and bony resorption.

Take CME Now

Human facial aging is a gradual and ongoing process involving various factors including photodamage, skin laxity, volume loss of subcutaneous tissue, and bony resorption.

As the aging US population is growing, minimally invasive strategies have become the primary treatment modalities for addressing mild to moderate age-related facial changes. The introduction of microfocused ultrasound (MFU) represents a method to produce a deeper wound healing response with increased collagen remodeling and more durable clinical response. MFU-V treatment protocols continue to be refined and use in combination with other minimally invasive strategies including injectable dermal fillers such as diluted calcium hydroxylapatite for skin laxity and appearance of lines in the neck and décolletage has been studied.

Need exists for expanded understanding of dermatology providers on the application of microfocused ultrasound in combination with injectable dermal fillers as a treatment approach for lifting skin on the neck and face and for improving lines and wrinkles on the chest

CME Certificate Information

  • This CME examination requires a 70% pass mark to receive the CME credit and certificate.
  • This activity is supported by an educational grant provided by Galderma Laboratories, L.P.

Upon completion of this continuing education activity participants should be able to:

  • Summarize the mechanism of action of high-resolution ultrasound imaging (MFU-V) for lifting skin on the neck and face, improving lines and wrinkles on the chest and improving collagen synthesis
  • Identify patients best suited for treatment with MFU-V in combination with injectable dermal fillers
  • Compare features, benefits, and safety profile MFU-V treatment in lifting skin on the neck and face and for improving lines and wrinkles on the chest
Take CME Now

You May Also Like

Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes

| Aesthetics, CME Activities, Featured Articles | No Comments
Earn 1.0 CME Credit: Human facial aging is a gradual and ongoing process involving various factors including photodamage, skin laxity, volume loss of subcutaneous tissue, and bony resorption.1 CME CreditHuman…

Expiring Soon: Capturing Consensus and Cutting Out Misconceptions regarding the Aesthetic Skin of Color Consumer

| CME Activities | No Comments
0.5 CME Credits Who knows what’s best/worst for facial aesthetics in the skin of color patient? No really who? Because there is a great deal of folklore and ballyhoo related…

Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update

| CME Activities | No Comments
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…

Expiring Soon: Capturing Consensus and Cutting Out Misconceptions regarding the Aesthetic Skin of Color Consumer

By CME Activities No Comments

CME Activities

"Capturing Consensus and Cutting Out misConceptions regarding the Aesthetic Skin of Color Consumer"

Who knows what’s best/worst for facial aesthetics in the skin of color patient? No really who? Because there is a great deal of folklore and ballyhoo related to what one can and cannot do, forgetting even what the patients think.
Enter Dr. Andrew Alexis, Professor and Chair of the Department of Dermatology at Mount Sinai St. Luke’s and Mount Sinai West and Director of the Skin of Color Center, with his experienced SOC entourage to marry personal experience and evidence (what a beautiful couple!).
Tune in to hear how it all went down. You couldn’t be in the room where it happened, but after this podcast you might have well been. Learn from one of the greats as I pick his brain on all things, medical and aesthetic, SOC. C to it you don’t miss this podcast.

To receive a CME certificate of participation, you should:

  • Listen to the Podcast Episode here
  • This CME examination requires a 70% pass mark to receive the CME credit and certificate.

Following online completion of the posttest and evaluation, a certificate of participation will be available for download/printing immediately.

Take CME Now

You May Also Like

Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes

| Aesthetics, CME Activities, Featured Articles | No Comments
Earn 1.0 CME Credit: Human facial aging is a gradual and ongoing process involving various factors including photodamage, skin laxity, volume loss of subcutaneous tissue, and bony resorption.1 CME CreditHuman…

Expiring Soon: Capturing Consensus and Cutting Out Misconceptions regarding the Aesthetic Skin of Color Consumer

| CME Activities | No Comments
0.5 CME Credits Who knows what’s best/worst for facial aesthetics in the skin of color patient? No really who? Because there is a great deal of folklore and ballyhoo related…

Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update

| CME Activities | No Comments
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…

Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update

By CME Activities No Comments

CME Activities

"Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update"

Since initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of facial anatomy have greatly increased, leading to rapid advances in treatment plan-ning and implementation.

BoNT-A use has expanded from the upper face to the midface, lower face, and neck, so that BoNT-A injection is the most common cosmetic procedure worldwide. Trends in facial aesthetics reflect growing patient diversity with respect to age, gender, and ethnicity. In October 2019, a multidisciplinary panel of 6 experts in minimally invasive injectable procedures in the special-ties of dermatology and plastic surgery convened at the 2019 American Society for Dermatologic Surgery (ASDS) meeting in Chicago, IL. Their goal was to discuss recent advances in BoNT-A use in facial aesthetics, including implications of the introduction of new agents in light of an evolving patient population.

To receive a CME certificate of participation, you should:

• Read the entire publication, including the CME information.
• Register or log in at www.paradigmmc.com/822 to complete and submit the online posttest and evaluation.

Following online completion of the posttest and evaluation, a certificate of participation will be available for download/printing immediately.

Take CME Now

You May Also Like

Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes

| Aesthetics, CME Activities, Featured Articles | No Comments
Earn 1.0 CME Credit: Human facial aging is a gradual and ongoing process involving various factors including photodamage, skin laxity, volume loss of subcutaneous tissue, and bony resorption.1 CME CreditHuman…

Expiring Soon: Capturing Consensus and Cutting Out Misconceptions regarding the Aesthetic Skin of Color Consumer

| CME Activities | No Comments
0.5 CME Credits Who knows what’s best/worst for facial aesthetics in the skin of color patient? No really who? Because there is a great deal of folklore and ballyhoo related…

Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update

| CME Activities | No Comments
1 CME CreditSince initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of…

Choosing Wisely: Capitalizing on Atopic Dermatitis Clinical Trial Data for Meaningful Selection of Topical Agents

By Podcast Highlights No Comments

We are finally getting what we asked for: Pharma is ponying up for head to head studies to provide us with meaningful data to help make better clinical decisions. However, these valuable projects are often with systemic agents, such as biologics, leaving topical treatments in the dust.

To address this, Dr. Lawrence Eichenfield, Professor of Dermatology and Pediatrics, UCSD, and colleagues sought to make the most out of the data we do have on the litany of topical options for atopic dermatitis and provide efficacy and safety guidance (A for effort!).

Tune in to hear what this dream team concocted about creams. Hear how an expert approaches new atopic dermatitis patients. Don’t miss out – this is all very topical.

Listen Now

You May Also Like

Podcast HighlightsSkin Cancer
October 7, 2020

Understanding and Changing Patient Behavior and Minimizing Risk of UV Damage

iTunes Google Play Stitcher TuneIn Drs. Sherry Pagoto and Adam Friedman   Why is is that we tend to do things we know are bad for us? Candy, alcohol, Tinder...the…
PhotoprotectionPodcast HighlightsSkin Cancer
September 10, 2020

NEW from the JDD Podcast: “The Science of Sun Protection”

iTunes Google Play Stitcher TuneIn Dr. Neal Bhatia and Dr. Adam Friedman   Photoprotection works, plain and simple. Yet all too often we must defend good science, dispel unfounded myths,…
Podcast HighlightsSkin Cancer
September 8, 2020

Support the (On)cause: A Practical Review of Supportive Oncodermatology

iTunes Google Play Stitcher TuneIn Drs. Mario Lacouture and Adam Friedman   Cancer sucks, plain and simple. What is often overlooked is that the life saving/altering therapies often come with…

Don’t Go Zero to TEN: Identifying Gaps that Lead to Drug Re-exposure in Toxic Epidermal Necrolysis

By Podcast Highlights

We’ve all been there – that dreaded middle of the night page/call from the ER. Three simple words that send us spinning: “Rule out TEN.”

Have no fear though, because the skin sloughing savoir is here. Inpatient dermatology service director Dr. Helena Pasieka joins us to discuss her recent research that elucidates opportunities to prevent offending agent re-exposure (aka first time shame on you, second time shame on us) in patients with a history of SJS/TEN.
Simple steps can be taken to improve communication and prevention. Even more importantly, Dr. Pasieka walks us through her tried and true approach to that r/o call, key findings to guide your decision making, and what to when. Listening to this podcast may save someone’s life…
Listen Now!

You May Also Like

Podcast HighlightsSkin Cancer
October 7, 2020

Understanding and Changing Patient Behavior and Minimizing Risk of UV Damage

iTunes Google Play Stitcher TuneIn Drs. Sherry Pagoto and Adam Friedman   Why is is that we tend to do things we know are bad for us? Candy, alcohol, Tinder...the…
PhotoprotectionPodcast HighlightsSkin Cancer
September 10, 2020

NEW from the JDD Podcast: “The Science of Sun Protection”

iTunes Google Play Stitcher TuneIn Dr. Neal Bhatia and Dr. Adam Friedman   Photoprotection works, plain and simple. Yet all too often we must defend good science, dispel unfounded myths,…
Podcast HighlightsSkin Cancer
September 8, 2020

Support the (On)cause: A Practical Review of Supportive Oncodermatology

iTunes Google Play Stitcher TuneIn Drs. Mario Lacouture and Adam Friedman   Cancer sucks, plain and simple. What is often overlooked is that the life saving/altering therapies often come with…